Popular searches: AAPL TSLA NVDA MSFT GOOGL

MIRM Stock Price Prediction 2026

Mirum Pharmaceuticals, Inc. Common Stock

$103.22
+$0.30 (+0.29%)

AI-powered price predictions based on fundamental analysis and growth projections

Last Updated: January 30, 2026
🎯
AI TRADING RECOMMENDATION
Evaluate position
Key Signals:
  • MACD converging near zero line - potential energy building
  • Volume showing accumulation (CMF: 0.4657)
MACD: Bullish | Volume: Accumulation
Fair Value Estimate
0.0% Overvalued
Fair Value: $103.22 (Current: $103.22)

Based on PEG ratio analysis, this stock appears overvalued at current levels. Consider waiting for a better entry point or reassess fundamentals.

PEG Ratio
309.04
Expensive
Current P/E
2000.00
Fair P/E
2000.00
Earnings Growth
6.5%
📈

Volume Trend: Accumulation

Institutional Buying Detected - Smart money is accumulating shares

Chaikin Money Flow (CMF): 0.466
Money Flow Index (MFI): 87.2

Positive CMF indicates money flowing into the stock. This bullish signal suggests institutional interest.

Options Analysis: 1-Year Target Strategy

Score: 36/100

Analysis comparing options pricing vs AI growth projections. This helps identify if options are cheap (buy calls) or expensive (sell premium).

HOLD - Marginal value
Wall Street Target
$98.60
+22.0% upside
Best Strike Found
$90.00
Exp: Dec. 18, 2026, midnight
Call Premium
$6.48
8.0% of stock price
Breakeven Price
$96.48
✓ Below target
Implied Probability
36.9%
Market's confidence
Value Score
32.7
Good buy
📈
POTENTIAL BUYING OPPORTUNITY
Options pricing suggests value relative to Wall Street analyst target

The $90 call expiring Dec 18, 2026 costs $6.48. If MIRM reaches the Wall Street analyst target of $98.60, this option would be profitable with a 32.7% return.

Note: Options involve significant risk. Only invest what you can afford to lose.

Open Interest: 0 | Volume: 4
Data as of: Dec 22, 2025
How to Use This Analysis: Value Score shows profitability if the 1-year growth target is reached. Positive score = profitable for buyers. Negative score = profit opportunity for premium sellers (covered calls, credit spreads).
Price Targets by Timeframe
Based on Wall Street analyst consensus targets
Timeframe Target Price Potential Return
30 Days $103.75 +0.5%
90 Days $104.89 +1.6%
6 Months $106.56 +3.2%
1 Year $109.90 +6.5%

More MIRM Analysis

Why is MIRM Moving? Buy or Sell MIRM? MIRM Full Analysis MIRM Trendline Analysis
MIRM Price Prediction Trendline

Scenario Analysis (1-Year Outlook)

Bull Case
30% Probability
$137.38 (+33.1%)

Best case scenario if strong fundamentals and market conditions align

Base Case
50% Probability
$109.90 (+6.5%)

Expected scenario based on current growth trajectory

Bear Case
20% Probability
$76.93 (-25.5%)

Downside scenario if market headwinds or disappointing results

Technical Indicators

RSI (14)
76.5
Overbought
MACD Signal
Bullish
Trend
Uptrend
Money Flow (CMF)
0.47

Key Fundamentals

Forward P/E
2000.00
P/S Ratio (TTM)
12.80x
High Premium
Revenue Growth (QoQ)
0.5%
Market Cap
$6,039M
Analyst Target
$109.90
52-Week High
$103.22
52-Week Low
$101.56

Options Activity

Alert Score
78/100
Classification
Moderate Alert
Unusual Activity
73.4
IV Spike
+117.8%

Recommendation: Moderate unusual activity. Monitor closely.

Investment Disclaimer: These price predictions are generated using AI models and historical data. They are not financial advice and should not be the sole basis for investment decisions. Past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Buy or Sell Analysis Trendline Analysis Investment Advisor Options Advisor Options Chain & Analysis